BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 30759030)

  • 1. Biology and targeting of the Jumonji-domain histone demethylase family in childhood neoplasia: a preclinical overview.
    McCann TS; Sobral LM; Self C; Hsieh J; Sechler M; Jedlicka P
    Expert Opin Ther Targets; 2019 Apr; 23(4):267-280. PubMed ID: 30759030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. KDM4 histone demethylase inhibitors for anti-cancer agents: a patent review.
    Chin YW; Han SY
    Expert Opin Ther Pat; 2015 Feb; 25(2):135-44. PubMed ID: 25468267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. JARID1 Histone Demethylases: Emerging Targets in Cancer.
    Harmeyer KM; Facompre ND; Herlyn M; Basu D
    Trends Cancer; 2017 Oct; 3(10):713-725. PubMed ID: 28958389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Jumonji histone demethylases as emerging therapeutic targets.
    Park SY; Park JW; Chun YS
    Pharmacol Res; 2016 Mar; 105():146-51. PubMed ID: 26816087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temperature influences histone methylation and mRNA expression of the Jmj-C histone-demethylase orthologues during the early development of the oyster Crassostrea gigas.
    Fellous A; Favrel P; Riviere G
    Mar Genomics; 2015 Feb; 19():23-30. PubMed ID: 25224965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting epigenetic regulators to overcome drug resistance in cancers.
    Wang N; Ma T; Yu B
    Signal Transduct Target Ther; 2023 Feb; 8(1):69. PubMed ID: 36797239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia causes epigenetic gene regulation in macrophages by attenuating Jumonji histone demethylase activity.
    Tausendschön M; Dehne N; Brüne B
    Cytokine; 2011 Feb; 53(2):256-62. PubMed ID: 21131212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of KDM3A as a therapeutic target in Ewing Sarcoma and other cancers.
    Jedlicka P
    Expert Opin Ther Targets; 2017 Nov; 21(11):997-999. PubMed ID: 29022407
    [No Abstract]   [Full Text] [Related]  

  • 9. Genome-wide identification, classification and expression analysis of the JmjC domain-containing histone demethylase gene family in maize.
    Qian Y; Chen C; Jiang L; Zhang J; Ren Q
    BMC Genomics; 2019 Apr; 20(1):256. PubMed ID: 30935385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the histone demethylase KDM4A in cancer.
    Guerra-Calderas L; González-Barrios R; Herrera LA; Cantú de León D; Soto-Reyes E
    Cancer Genet; 2015 May; 208(5):215-24. PubMed ID: 25633974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone demethylases in physiology and cancer: a tale of two enzymes, JMJD3 and UTX.
    Arcipowski KM; Martinez CA; Ntziachristos P
    Curr Opin Genet Dev; 2016 Feb; 36():59-67. PubMed ID: 27151432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unravelling KDM4 histone demethylase inhibitors for cancer therapy.
    Baby S; Gurukkala Valapil D; Shankaraiah N
    Drug Discov Today; 2021 Aug; 26(8):1841-1856. PubMed ID: 34051367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic gene regulation by plant Jumonji group of histone demethylase.
    Chen X; Hu Y; Zhou DX
    Biochim Biophys Acta; 2011 Aug; 1809(8):421-6. PubMed ID: 21419882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Jumonji gene family in Crassostrea gigas suggests evolutionary conservation of Jmj-C histone demethylases orthologues in the oyster gametogenesis and development.
    Fellous A; Favrel P; Guo X; Riviere G
    Gene; 2014 Mar; 538(1):164-75. PubMed ID: 24406622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel Scaffolds of Cell-Active Histone Demethylase Inhibitors Identified from High-Throughput Screening.
    Wang W; Marholz LJ; Wang X
    J Biomol Screen; 2015 Jul; 20(6):821-7. PubMed ID: 25883088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone demethylase lysine demethylase 5B in development and cancer.
    Han M; Xu W; Cheng P; Jin H; Wang X
    Oncotarget; 2017 Jan; 8(5):8980-8991. PubMed ID: 27974677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting the Jumonji family: a potential new clinical approach to targeting aberrant epigenetic mechanisms.
    Martinez ED; Gazdar AF
    Epigenomics; 2016 Mar; 8(3):313-6. PubMed ID: 26918824
    [No Abstract]   [Full Text] [Related]  

  • 18. Ascorbic acid modulates immune responses through Jumonji-C domain containing histone demethylases and Ten eleven translocation (TET) methylcytosine dioxygenase.
    Maity J; Majumder S; Pal R; Saha B; Mukhopadhyay PK
    Bioessays; 2023 Nov; 45(11):e2300035. PubMed ID: 37694689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone demethylase JMJD3 at the intersection of cellular senescence and cancer.
    Perrigue PM; Najbauer J; Barciszewski J
    Biochim Biophys Acta; 2016 Apr; 1865(2):237-44. PubMed ID: 26957416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JMJD3 as an epigenetic regulator in development and disease.
    Burchfield JS; Li Q; Wang HY; Wang RF
    Int J Biochem Cell Biol; 2015 Oct; 67():148-57. PubMed ID: 26193001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.